Division of Bariatric, Foregut and Advanced Gastrointestinal Surgery, Department of Surgery, Health Sciences Center T18-040, Stony Brook University Medical Center, 100 Nichols Road, HSC T19, Stony Brook, NY, 11794, USA.
Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, 11794, USA.
Surg Endosc. 2021 Jul;35(7):3923-3931. doi: 10.1007/s00464-020-07848-2. Epub 2020 Aug 3.
While bariatric surgery has been shown to improve type 2 diabetes (DM) control in the obese population, the effect on long-term DM complications has been less thoroughly investigated. The purpose of this study was to assess the development of microvascular and macrovascular complications in obese DM patients undergoing bariatric surgery.
New York patients' records from the SPARCS database in years 2006-2012 were used to identify obese patients with DM. Patients undergoing bariatric surgery were compared with patients managed medically, matched for age and gender. Patients were grouped based on baseline presence of controlled or uncontrolled DM and followed over time for the development of micro- and macrovascular complications. Cumulative incidence of complications was estimated with death treated as a competing risk event. Multivariable proportional sub-distribution hazards models were used to compare the risk of complications among different patient groups after adjusting for possible confounding factors.
A total of 88,981 patients were reviewed, including 15,585 (18%) that were treated with bariatric surgery. Surgery patients had significantly lower risk of microvascular complications compared to non-surgery patients (controlled diabetes: HR = 0.40, 95% CI 0.37-0.42; uncontrolled diabetes: HR = 0.51, 95% CI 0.37-0.71). Similarly, the surgical patients were noted to have a significantly lower risk for macrovascular complications compared to non-surgery patients (controlled diabetes: HR = 0.43, 95% CI 0.40-0.46; uncontrolled diabetes: HR = 0.44, 95% CI 0.28-0.69). Cumulative incidence of microvascular complications was lower at 1, 5 and 9 years for the surgical groups for controlled and uncontrolled DM. Similar trends were observed for the macrovascular complications.
Bariatric surgery appears to prevent complications of DM. Bariatric surgery patients with DM experienced significantly lower rates of microvascular and macrovascular complications, compared to non-surgically treated comparison group. Bariatric surgery was noted to offer protective benefits for both complicated and non-complicated DM patients. This reduced rate of complications was sustained in the long term.
减重手术已被证明可改善肥胖人群 2 型糖尿病(DM)的控制,但对长期 DM 并发症的影响研究较少。本研究旨在评估肥胖 DM 患者接受减重手术后微血管和大血管并发症的发展情况。
使用 2006-2012 年 SPARCS 数据库中的纽约患者记录,确定患有 DM 的肥胖患者。将接受减重手术的患者与接受药物治疗的患者进行比较,两组患者在年龄和性别上相匹配。根据基线时 DM 控制情况将患者分为控制组和未控制组,然后随访观察微血管和大血管并发症的发生情况。使用竞争风险事件处理死亡的累积发生率估计并发症的发生情况。多变量比例亚分布风险模型用于调整可能的混杂因素后,比较不同患者组发生并发症的风险。
共回顾了 88981 例患者,其中 15585 例(18%)接受了减重手术。与非手术患者相比,手术患者发生微血管并发症的风险显著降低(控制糖尿病:HR=0.40,95%CI 0.37-0.42;未控制糖尿病:HR=0.51,95%CI 0.37-0.71)。同样,与非手术患者相比,手术患者发生大血管并发症的风险也显著降低(控制糖尿病:HR=0.43,95%CI 0.40-0.46;未控制糖尿病:HR=0.44,95%CI 0.28-0.69)。对于控制和未控制的 DM,手术组在 1、5 和 9 年时微血管并发症的累积发生率较低。大血管并发症也观察到了类似的趋势。
减重手术似乎可以预防 DM 并发症。与非手术治疗的对照组相比,患有 DM 的减重手术患者发生微血管和大血管并发症的风险显著降低。减重手术对复杂和非复杂 DM 患者均具有保护作用。这种并发症发生率的降低在长期内是持续存在的。